CNV subtype in first eyes predicts severity of ARM in fellow eyes
- PMID: 12598444
- PMCID: PMC1771546
- DOI: 10.1136/bjo.87.3.307
CNV subtype in first eyes predicts severity of ARM in fellow eyes
Abstract
Aim: To examine the relation between the type of choroidal neovascularisation (CNV) in the first eye and age related maculopathy (ARM) severity in the fellow eye.
Methods: Colour fundus photographs and fluorescein angiograms from 67 subjects with a clinical diagnosis of CNV in one eye were scrutinised. CNV was classified as wholly classic, predominantly classic, minimally classic, or occult based on the proportion of classic leakage within the lesion. ARM changes in the fellow eye were assigned a severity stage using the system described by the Rotterdam Eye Study. Logistic regression analysis was employed to examine the association between CNV subtype and ARM stage.
Results: Of subjects with classic or predominantly classic CNV in the first eye 78% exhibited least no or early ARM features in the fellow eye. By contrast, 85% of subjects with minimally classic or occult CNV in the first eye exhibited more advanced ARM features in the fellow eye. Kruskall-Wallis one way ANOVA by ranks showed that this was highly significant (p = 0.002). Logistic regression analysis showed that as the proportion of occult CNV increased in the first eye, fellow eyes of subjects in this category were more likely to have been assigned to a higher ARM stage (p = 0.019). The area occupied by the CNV in the first eye also influenced severity of ARM changes in the fellow eye.
Conclusion: The type and extent of CNV in the first affected eye has a distinct relation to ARM severity in the fellow eye. Fellow eyes of subjects with minimally classic or occult CNV in the first affected eye show widespread ARM changes suggestive of retinal pigment epithelial dysfunction. These findings suggest that classic CNV may be focal disease while occult CNV is essentially a more widespread retinal pigment epithelial disorder.
Figures


Comment in
-
CNV subtype in first eyes predicts severity of ARM in fellow eyes.Br J Ophthalmol. 2004 Jan;88(1):155. doi: 10.1136/bjo.88.1.155-a. Br J Ophthalmol. 2004. PMID: 14693798 Free PMC article. No abstract available.
Similar articles
-
Fundus autofluorescence in exudative age-related macular degeneration.Br J Ophthalmol. 2007 Apr;91(4):491-6. doi: 10.1136/bjo.2006.095109. Epub 2006 Sep 6. Br J Ophthalmol. 2007. PMID: 16956913 Free PMC article.
-
Natural course of occult choroidal neovascularization in age-related macular degeneration: development of classic lesions in fluorescein angiography.Acta Ophthalmol Scand. 2005 Apr;83(2):141-7. doi: 10.1111/j.1600-0420.2005.00443.x. Acta Ophthalmol Scand. 2005. PMID: 15799723
-
Choroidal neovascularization in second eyes of patients with unilateral exudative age-related macular degeneration.Ophthalmology. 1995 Sep;102(9):1380-6. doi: 10.1016/s0161-6420(95)30860-3. Ophthalmology. 1995. PMID: 9097777
-
Incident choroidal neovascularization in fellow eyes of patients with unilateral subfoveal choroidal neovascularization secondary to age-related macular degeneration: SST report No. 20 from the Submacular Surgery Trials Research Group.Arch Ophthalmol. 2007 Oct;125(10):1323-30. doi: 10.1001/archopht.125.10.1323. Arch Ophthalmol. 2007. PMID: 17923538 Clinical Trial.
-
[A new approach for studying the retinal and choroidal circulation].Nippon Ganka Gakkai Zasshi. 2004 Dec;108(12):836-61; discussion 862. Nippon Ganka Gakkai Zasshi. 2004. PMID: 15656089 Review. Japanese.
Cited by
-
CNV subtype in first eyes predicts severity of ARM in fellow eyes.Br J Ophthalmol. 2004 Jan;88(1):155. doi: 10.1136/bjo.88.1.155-a. Br J Ophthalmol. 2004. PMID: 14693798 Free PMC article. No abstract available.
-
Prognosis of untreated occult choroidal neovascularization.Graefes Arch Clin Exp Ophthalmol. 2007 Mar;245(3):376-84. doi: 10.1007/s00417-006-0424-1. Epub 2006 Oct 27. Graefes Arch Clin Exp Ophthalmol. 2007. PMID: 17072636
-
Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration.BMC Ophthalmol. 2020 Sep 25;20(1):381. doi: 10.1186/s12886-020-01651-2. BMC Ophthalmol. 2020. PMID: 32977799 Free PMC article.
-
Efficacy of Aflibercept as initial treatment for neovascular age-related macular degeneration in an Iraqi patient sample.J Med Life. 2023 Feb;16(2):235-243. doi: 10.25122/jml-2022-0356. J Med Life. 2023. PMID: 36937463 Free PMC article.
-
Treatment of age-related macular degeneration: focus on ranibizumab.Clin Ophthalmol. 2008 Mar;2(1):1-14. doi: 10.2147/opth.s1959. Clin Ophthalmol. 2008. PMID: 19668384 Free PMC article.
References
-
- The International ARM Epidemiological Study Group. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Ophthalmology 1995;39:367–74 - PubMed
-
- Klaver CCW, Assink JJM, van Leeuwen R, et al. Incidence and progression rates of age-related maculopathy:The Rotterdam Study. Invest Ophthalmol 2001;72:2237–41 - PubMed
-
- Roy M, Kaiser Kupfer M. Second eye involvement in age-related macular degeneration. A four year prospective study. Eye 1990;4:813–18. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical